SF2809 compounds, novel chymase inhibitors from Dactylosporangium sp. 1. Taxonomy, fermentation, isolation and biological properties

Journal of Antibiotics

Volumn 57, Issue 2, 2004, Pages 83-88

  Tani, Masato ^a   Gyobu, Yasuhiro ^a   Sasaki, Toru ^a   Takenouchi, Osami ^b   Kawamura, Takashi ^b   Kamimura, Takashi ^b   Harada, Toshiaki ^b  

^a MEIJI SEIKA KAISHA LTD   (Japan)

^b TEIJIN LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CATHEPSIN G; CHYMASE; CHYMASE INHIBITOR; CHYMOTRYPSIN; ENZYME INHIBITOR; SERINE PROTEINASE; SF 2809 I; SF 2809 II; SF 2809 III; SF 2809 IV; SF 2809 V; SF 2809 VI; UNCLASSIFIED DRUG;

ACTINOMYCES; ARTICLE; BACTERIAL STRAIN; CHEMOTAXONOMY; CONTROLLED STUDY; DACTYLOSPORANGIUM; DRUG ISOLATION; DRUG SYNTHESIS; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SPECIFICITY; FERMENTATION MEDIUM; IC 50; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

DACTYLOSPORANGIUM;

EID: 1642564619     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.57.83     Document Type: Article

References (28)

1. Urata, H.; A. Kinoshita, K. S. Misono, F. M. Bumpus & A. Husain: Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J. Biol. Chem. 265: 22348-22357, 1990
2. Caughey, G. H.; S. C. Lazarus, N. F. Viro, W. M. Gold & J. A. Nadel: Tryptase Cnd chymase: comparison of extraction release in two dog mastcytoma lines. Immunology 63: 339-344, 1988
3. Takai, S.; N. Shiota, D. Jin & M. Miyazaki: Chymase processes big-endothelin-2 to endothelin-2-(31) that induces contractile responses in the isolated monkey trachea. Eur. J. Pharmacol. 358: 229-233, 1998
4. Mizutani, H.; N. Schechter, G. Lazarus, R. A. Black & T. S. Kupper: Rapid and specific conversion of precursor interleukin 1β (IL-1β) to an active IL-1 species by human mast cell chymase. J. Exp. Med. 174: 821-825, 1991
5. Taipale, J.; J. Lohi, J. Saarinen, P. T. Kovanen & J. K- Oja: Human mast cell chymase and leukocyte elastase release transforming growth factor-β1 from the extracellular matrix of cultured human epithelial and endothelial cells. J. Biol. Chem. 270: 4689-4696, 1995
6. Kato, Y.; H. Kido, N. Fukusen & N. Katunuma: Peptide boronic acids, substrate analogs, inhibit chymase, and histamine release from mast cells. J. Biochem. 103: 820-822, 1988
7. Sommerhoff, C. P.; G. H. Caughey, W. E. Finkbeiner, S. C. Lazarus, C. BA Basbaum & J. A. Nadel: Mast cell chymase: a potent secretagogue for airway gland serous cells. J. Immunol. 142: 2450-2456, 1989
8. Mao, X. Q.; T. Shirakawa, T. Yoshikawa, K. Yoshikawa, M. Kawai, S. Sasaki, T. Enomoto, T. Hashimoto, J. Furuyama, J. M. Hapkin & K. Morimoto: Association between genetic variants of mast-cell chymase and eczema. Lancet 348: 581-583, 1996
9. Tanaka, K.; H. Sugiura, M. Uehara, H. Sato, T. Hashimoto-Tamaoki & J. Furuyama: Association between mast cell chymase genotype and atopic eczema: Comparison between patients with atopic eczema alone those with atopic eczema and atopic respiratory disease. Clin. Exp. Allergy 29: 800-803, 1999
10. Aoyama, Y.: Non-peptidic chymase inhibitors. Expert Opin. Ther. Patents 11: 1423-1428, 2001
11. Shiota, N.; A. Fukamizu, S. Takai, H. Okunishi, K. Murakami & M. Miyazaki: Activation of angiotensin II-forming chymase in the cardiomyopathic hamster heart. J. Hypertens. 15: 431-440, 1997
12. Takai, S. & M. Miyazaki: Development and application of chymase inhibitor: Effect of chymase inhibitor on vascular proliferation. Jpn. J. Pharmacol. 90: 223-227, 2002
13. Doggrell, S. A. & J. C. Wanstall: Will chymase inhibitors be the next major development for the treatment of cardiovascular disorders? Expert Opin. Investg. Drugs 12: 1429-1432, 2003
14. Sukenaga, Y.; K. Kamoshita, S. Takai & M. Miyazaki: Development and application of chymase inhibitors: Development of the chymase inhibitor as an anti-tissue-remodeling drug: Myocardial infarction and some other possibilities. Jpn. J. Pharmacol. 90: 218-222, 2002
15. Yamada, M.; M. Ueda, T. Naruko, S. Tanabe, Y-S. Han, Y. Ikura, M. Ogami, S. Takai & M. Miyazaki: Mast cell chymase expression and mast cell phenotypes in human rejected kidneys. Kidney Int. 59: 1374-1381, 2001
16. Tani, M.; K. Harimaya, Y. Gyobu, T. Sasaki, O. Takenouchi, T. Kawamura, T. Kamimura & T. Harada: SF2809 compounds, novel chymase inhibitors from Dactylosporangium sp. 2. Structural elucidation. J. Antibiotics 57: 89-96, 2004
17. Shirling, E. B. & D. Gottlieb: Methods for characterization of Streptomyces species. Int. J. Syst. Bacteriol. 16: 313-340, 1966
18. Waksman, S. A.: Classification, identification and description of genera and species. In The Actinomycetes. Vol. II. pp. 328-334. The Williams & Wilkins Co., Baltimore, 1961
19. Shomura, T.: Screening for new products of new species of Dactylosporangium and other actinomycetes. Actinomycetol. 7: 88-98, 1993
20. Color Harmony Manual, 4th Edition: Container Corporation of America, Chicago, U.S.A., 1958
21. Becker, B.; M. P. Lechevalier & H. A. Lechevalier: Chemical composition of cell-wall preparations from strains of various form-genera of aerobic actinomycetes. Appl. Microbiol. 13: 236-243, 1965
22. Lechevalier, M. P. & H. A. Lechevalier: The chemotaxonomy of actinomycetes. In Actinomycete taxonomy, Ed., A. Dietz & D. W. Thayer, pp. 227-291, Society for Industrial Microbiology, Virginia, 1980
23. Uchida, K.: Acyltype of actinomycete cell wall: Its simple identification by a glycolate test. The Actinomycetologist. 40: 28-31, 1982
24. Nakagawa, K. & H. Kawasaki: 16S rRNA gene sequencing method. In Identification Manual of Actinomycetes, Ed., S. Miyadoh, pp. 88-132, The Business Center for Academic Societies Japan, Tokyo, Japan, 2001
25. Murakami, M.; S. S. Karnic & A. Husain: Human Prochymase activation. J. Biol. Chem. 270: 2218-2223, 1995
26. Eda, M.; A. Ashimori, F. Akahishi, T. Yoshimura, Y. Inoue, C. Fukaya, M. Nakajima, H. Fukuyama, T. Imada & N. Nakamura: Peptidyl human heart chymase inhibitors. 1. Synthesis and inhibitory activity of difluoromethylene ketone derivatives bearing P' binding subsites. Bioorg. Med. Chem. Lett. 8: 913-918, 1998
27. Nakajima, K.; J. C. Powers, B. M. Ashe & M. Zimmerman: Mapping the extended binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha1-protease inhibitor reactive site. J. Biol. Chem. 254: 4027-4032, 1979
28. Ensign, J. C.: Formation, properties, and germination of actinomycetes spores. Ann. Rev. Microbiol. 32: 185-219, 1978